SIM
GLMD icon

Spark Investment Management’s Galmed Pharmaceuticals GLMD Stock Holding History

Spark Investment Management’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-52
Closed -$507K – 673
2018
Q4 		$507K Buy
+52
New +$727K 0.04% 400
2015
Q2 		– Sell
-8
Closed -$111K – 684
2015
Q1 		$111K Buy
8
+1
+14% +$12K 0.02% 609
2014
Q4 		$57K Buy
+7
New +$60.8K 0.01% 631

Other funds holding GLMD

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $194M AUM 23.58% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $131M AUM 35.16% 1-Year Est. Return

Spark Investment Management's GLMD Position: Q1 2019 in Review

Spark Investment Management sold out of Galmed Pharmaceuticals (GLMD) in Q1 2019, closing a stake of 52 shares — an estimated $507K sold.

Spark Investment Management first reported a position in GLMD in Q4 2014 and held it in 3 quarters. The position peaked at $507K in Q4 2018. 29 funds tracked by Wall St. Rank hold GLMD as of Q1 2019.

  • Spark Investment Management reported no remaining Galmed Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Spark Investment Management sold 52 Galmed Pharmaceuticals shares in Q1 2019, an estimated $507K.
  • Spark Investment Management first reported a position in Galmed Pharmaceuticals in Q4 2014 and held it in 3 quarters.
  • Spark Investment Management's Galmed Pharmaceuticals position peaked at $507K in Q4 2018.
  • 29 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q1 2019.

Based on Spark Investment Management's 13F filing for Q1 2019, filed 7 May 2019.